-
S John Weroha, MD, PhD,
Mayo Clinic
Early Career Investigator Grant
Ovarian Cancer Surrogates to Study Platinum Resistance
-
Ursula Matulonis, MD,
Dana Farber Cancer Institute
Collaborative Research Development Grant
Rational Combinations of Novel Biologic Agents for Ovarian Cancer Therapy
-
Nima Aghaeepour, PhD,
Stanford University
Mentored Investigator Grant
Computationally-guided Characterization of Therapy-resistant Ovarian Tumors
-
Raphael Ceccaldi, PharmD, PhD,
Dana Farber Cancer Institute
Mentored Investigator Grant
A Bioinformatic Screen Identifies POLQ Overexpression in Ovarian Cancers
-
Ilana Chefetz, PhD,
University of Michigan
Mentored Investigator Grant
A Role for ALDH in the Regulation of Necroptosis in Ovarian Cancer Area of research: Therapeutic Targeting
-
Ellen Cheon, PhD,
Cedars-Sinai Medical Center
Mentored Investigator Grant
Collagen-Remodeling Genes Provide a Niche for Ovarian Cancer
-
Laura Dillon, PhD,
University of Virginia
Mentored Investigator Grant
Differential MicroDNA Generation in Ovarian Cancer
-
Mo Li, PhD,
University of Michigan
Mentored Investigator Grant
Mechanism of PARP Inhibitor in Ovarian Cancer Therapy Cancer
-
Kyung Hee Noh, PhD,
MD Anderson Cancer Center
Mentored Investigator Grant
Targeting Adaptive Changes to anti-VEGF Therapy in Ovarian Cancer
-
Shailja Pathania, PhD,
Dana Farber Cancer Institute
Mentored Investigator Grant
Novel Therapeutic Targets for High-Grade Serous Ovarian Carcinoma
-
Megan Rice, ScD,
Brigham and Women’s Hospital
Mentored Investigator Grant
Dietary Fat, Cholesterol, and Ovarian Cancer Risk
-
Yang Yang, PhD,
Yale University
Mentored Investigator Grant
P53 Aggregation: a New Target to Combat Ovarian Cancer Platinum-Resistance